Cannabidiol is a negative allosteric modulator of the cannabinoid CB 1 receptor

Laprairie, R B, Bagher, A M, Kelly, M E M, Denovan‐Wright, E M·2015·British Journal of Pharmacology

DOI 10.1111/bph.13250

Cited by (1,000)

Items 101–200 of 1,000

Terpenoids, Cannabimimetic Ligands, beyond the Cannabis Plant
Elaine Cristina Dalazen Gonçalves, Gabriela Mantovani Baldasso, Maira Assunção Bicca, Rodrigo Sebben Paes, Raffaele Capasso, Rafael Cypriano Dutra · 2020 · Molecules
Cannabidiol Claims and Misconceptions
Ethan B. Russo · 2017 · Trends in Pharmacological Sciences
Cannabichromene is a cannabinoid CB 2 receptor agonist
Michael Udoh, Marina Santiago, Steven O. Devenish, Iain S. McGregor, Mark A. Connor · 2019 · British Journal of Pharmacology
ASRA Pain Medicine consensus guidelines on the management of the perioperative patient on cannabis and cannabinoids
Shalini Shah, Eric S. Schwenk, Rakesh Vijayashankar Sondekoppam, Hance A. Clarke, Mark I. Zakowski, Rachael Rzasa Lynn, Brent Yeung, Kate Nicholson, Gary S. Schwartz, William Michael Hooten et al. · 2023 · Regional Anesthesia & Pain Medicine
Enantiospecific Allosteric Modulation of Cannabinoid 1 Receptor
Robert B. Laprairie, Pushkar M. Kulkarni, Jeffrey R. Deschamps, Melanie E. M. Kelly, David R. Janero, Maria Grazia Cascio, Lesley Stevenson, Roger G. Pertwee, Terrence Kenakin, Eileen M. Denovan‐Wright et al. · 2017 · ACS Chemical Neuroscience
Corrigendum: Potential Clinical Benefits of CBD-Rich Cannabis Extracts Over Purified CBD in Treatment-Resistant Epilepsy: Observational Data Meta-analysis
Fabrício A. Pamplona, Lorenzo Rolim da Silva, Ana Carolina Coan · 2019 · Frontiers in Neurology
GPR55: A therapeutic target for Parkinson's disease?
Marta Celorrio, Estefanía Rojo-Bustamante, Diana Fernández‐Suárez, Elena Sáez, Ander Estella‐Hermoso de Mendoza, Christa Elisabeth Müller, María Javier Ramírez, Julen Oyarzábal, Rafael Franco, María S. Aymerich · 2017 · Neuropharmacology
Cannabis Phytomolecule 'Entourage': From Domestication to Medical Use
Hinanit Koltai, Dvora Namdar · 2020 · Trends in Plant Science
Vaporized Cannabis Extracts Have Reinforcing Properties and Support Conditioned Drug-Seeking Behavior in Rats
Timothy G. Freels, Lydia N. Baxter-Potter, Janelle M. Lugo, Nicholas C. Glodosky, Hayden R. Wright, Samantha L. Baglot, Gavin N. Petrie, Zhihao Yu, Brian H. Clowers, Carrie Cuttler et al. · 2020 · Journal of Neuroscience
Use of cannabidiol (CBD) for the treatment of chronic pain
Ivan Urits, Kyle L. Gress, Karina Charipova, Kelly Habib, David Michael Lee, Christopher Seungkyu Lee, Jai Won Jung, Hisham Kassem, Elyse M. Cornett, Antonella Paladini et al. · 2020 · Best practice & research. Clinical anaesthesiology
Cannabigerol Is a Potential Therapeutic Agent in a Novel Combined Therapy for Glioblastoma
Tamara T. Lah, Metka Novak, Milagros A. Pena Almidon, Oliviero Marinelli, Barbara Žvar Baškovič Gantar, Bernarda Majc, Mateja Mlinar, Róman Boŝnjak, Barbara Breznik, Roby Zomer et al. · 2021 · Cells
Overcoming the Psychiatric Side Effects of the Cannabinoid CB1 Receptor Antagonists: Current Approaches for Therapeutics Development
Thuy Nguyen, Brian F. Thomas, Yanan Zhang · 2019 · Current Topics in Medicinal Chemistry
Molecular Mechanism and Cannabinoid Pharmacology
Lesley D. Schurman, Dai Lu, Debra A. Kendall, Allyn C. Howlett, Aron H. Lichtman · 2019 · Handbook of experimental pharmacology
Potential and Limits of Cannabinoids in Alzheimer’s Disease Therapy
Giulia Abate, Daniela Letizia Uberti, Simone Tambaro · 2021 · Biology
The Interplay between the Endocannabinoid System, Epilepsy and Cannabinoids
Keith A. Kwan Cheung, Hassendrini N. Peiris, Geoff Wallace, Olivia J. Holland, Murray David Mitchell · 2019 · International Journal of Molecular Sciences
Therapeutic and clinical foundations of cannabidiol therapy for difficult-to-treat seizures in children and adults with refractory epilepsies
Doodipala Samba Reddy · 2022 · Experimental Neurology
Terpenoids From Cannabis Do Not Mediate an Entourage Effect by Acting at Cannabinoid Receptors
Finlay, David B., Sircombe, Kathleen J., Nimick, Mhairi, Jones, Callum, Glass, Michelle · 2020 · Frontiers in Pharmacology
GPR3 and GPR6, novel molecular targets for cannabidiol
Alyssa S. Laun, Zhao-Hui Song · 2017 · Biochemical and Biophysical Research Communications
The heterogeneity and complexity of Cannabis extracts as antitumor agents
Liran Baram, Ella Peled, Paula Berman, Ben Yellin, Elazar Besser, Maya Benami, Igal Louria‐Hayon, Gil Moshe Lewitus, David Meiri · 2019 · Oncotarget
Cannabinoids in the Pathophysiology of Skin Inflammation
Cristian Scheau, Ioana Anca Bădărău, Livia-Gratiela Mihai, Andreea-Elena Scheau, Daniel Octavian Costache, Carolina Constantin, Daniela Cornelia Călina, Constantin Căruntu, Raluca Simona Costache, Ana Căruntu · 2020 · Molecules
Cannabidiol Therapy for Refractory Epilepsy and Seizure Disorders
Victoria M. Golub, Doodipala Samba Reddy · 2020 · Advances in experimental medicine and biology
Functional dynamics of G protein-coupled receptors reveal new routes for drug discovery
Paolo Conflitti, Edward R. Lyman, Mark S.P. Sansom, Peter Werner Hildebrand, Hugo Gutiérrez‐de‐Terán, Paolo Carloni, T. Bertie Ansell, Shuguang Yuan, Patrick Barth, Anne Skaja Robinson et al. · 2025 · Nature Reviews Drug Discovery
Cannabidiol skews biased agonism at cannabinoid CB1 and CB2 receptors with smaller effect in CB1-CB2 heteroreceptor complexes
Gemma Navarro, Irene Reyes‐Resina, Rafael Rivas‐Santisteban, Verónica Sánchez de Medina, Paula Morales, Salvatore Casano, Carlos Ferreiro‐Vera, Alejandro Lillo, David Aguinaga, Nadine Jagerovic et al. · 2018 · Biochemical Pharmacology
Co-administration of cannabidiol and capsazepine reduces L-DOPA-induced dyskinesia in mice: Possible mechanism of action
Maurício dos Santos Pereira, Célia Aparecida da-Silva, Francisco Silveira Guimarães, Elaine Aparecida Del Bel · 2016 · Neurobiology of Disease
Biased Type 1 Cannabinoid Receptor Signaling Influences Neuronal Viability in a Cell Culture Model of Huntington Disease
Robert B. Laprairie, Amina M. Bagher, Melanie E.M. Kelly, Eileen M. Denovan‐Wright · 2015 · Molecular Pharmacology
Allosteric Modulation: An Alternate Approach Targeting the Cannabinoid CB1 Receptor
Thuy Nguyen, Jun‐Xu Li, Brian F. Thomas, Jenny L. Wiley, Terry Kenakin, Yanan Zhang · 2016 · Medicinal Research Reviews
Cannabis as a cause of death: A review
Olaf H. Drummer, Dimitri Gerostamoulos, Noel W. F. Woodford · 2019 · Forensic Science International
Cannabidiol as a Potential New Type of an Antipsychotic. A Critical Review of the Evidence
Cathrin Rohleder, Juliane K. Müller, Bettina Lange, F. Markus Leweke · 2016 · Frontiers in Pharmacology
Emerging evidence for the antidepressant effect of cannabidiol and the underlying molecular mechanisms
Gabriela Pandini Silote, Ariandra Guerini Sartim, Amanda J. Sales, Amanda Eskelund, Francisco Silveira Guimarães, Gregers Wegener, Sâmia R.L. Joca · 2019 · Journal of Chemical Neuroanatomy
Combination of Cannabinoids, Δ9- Tetrahydrocannabinol and Cannabidiol, Ameliorates Experimental Multiple Sclerosis by Suppressing Neuroinflammation Through Regulation of miRNA-Mediated Signaling Pathways
Zinah Zamil Al-Ghezi, Kathryn Miranda, Mitzi Nagarkatti, Prakash S. Nagarkatti · 2019 · Frontiers in Immunology
Pharmacological data of cannabidiol- and cannabigerol-type phytocannabinoids acting on cannabinoid CB1, CB2 and CB1/CB2 heteromer receptors
Gemma Navarro, Katia Varani, Alejandro Lillo, Fabrizio Vincenzi, Rafael Rivas‐Santisteban, Iu Raïch, Irene Reyes‐Resina, Carlos Ferreiro‐Vera, Pier Andrea Borea, Verónica Sánchez de Medina et al. · 2020 · Pharmacological Research
Allosteric Modulators of the CB 1 Cannabinoid Receptor: A Structural Update Review
Paula Morales, Pilar Goya, Nadine Jagerovic, Laura Hernández‐Folgado · 2016 · Cannabis and Cannabinoid Research
Cannabinoids in the Treatment of Epilepsy: Current Status and Future Prospects
Alessandra Morano, Martina Fanella, Mariarita Albini, Pierangelo Cifelli, Eleonora Palma, Anna Teresa Giallonardo, Carlo Di Bonaventura · 2020 · Neuropsychiatric Disease and Treatment
Molecular Targets of Cannabidiol in Experimental Models of Neurological Disease
Serena Silvestro, Giovanni Schepici, Placido Bramanti, Emanuela Mazzon · 2020 · Molecules
The endocannabinoid system as a target for addiction treatment: Trials and tribulations
Matthew E. Sloan, Joshua L. Gowin, Vijay A. Ramchandani, Yasmin L. Hurd, Bernard Le Foll · 2017 · Neuropharmacology
Pharmacological properties of cannabidiol in the treatment of psychiatric disorders: a critical overview
Gian Mario Mandolini, Matteo Lazzaretti, Alessandro Pigoni, Lucio Oldani, Giuseppe Delvecchio, Paolo Brambilla · 2018 · Epidemiology and Psychiatric Sciences
Peripubertal cannabidiol treatment rescues behavioral and neurochemical abnormalities in the MAM model of schizophrenia
Tibor Štark, Jana Kučerová, Fabio Arturo Iannotti, Claudio D’Addario, Roberta Di Marco, Vladimír Pekařík, Eva Dražanová, Fabiana Piscitelli, Monica Bari, Zuzana Babinská et al. · 2018 · Neuropharmacology
Dark Classics in Chemical Neuroscience: Δ 9 -Tetrahydrocannabinol
Samuel D. Banister, Jonathon Carl Arnold, Mark A. Connor, Michelle Glass, Iain S. McGregor · 2019 · ACS Chemical Neuroscience
The Pharmacology and Therapeutic Potential of Plant Cannabinoids
Maria Grazia Cascio, Roger G. Pertwee, Pietro Marini · 2017 · Springer eBooks
Cannabidiol alleviates neuroinflammation and attenuates neuropathic pain via targeting FKBP5
Xue Wang, Cong Lin, Cong Lin, Yibo Wang, Yibo Wang, Xiaohui Wang · 2023 · Brain Behavior and Immunity
Cannabidiol Inhibits Endocannabinoid Signaling in Autaptic Hippocampal Neurons
Alex J. Straiker, Michaela Dvořáková, Anaëlle Zimmowitch, Ken Mackie · 2018 · Molecular Pharmacology
Could the Combination of Two Non-Psychotropic Cannabinoids Counteract Neuroinflammation? Effectiveness of Cannabidiol Associated with Cannabigerol
Santa Mammana, Eugenio Cavalli, Agnese Gugliandolo, Serena Silvestro, Federica Pollastro, Placido Bramanti, Emanuela Mazzon · 2019 · Medicina
Endocannabinoids, cannabinoids and the regulation of anxiety
Gavin N. Petrie, Andrei S. Nastase, Robert J. Aukema, Matthew N. Hill · 2021 · Neuropharmacology
Reviewing the Role of the Endocannabinoid System in the Pathophysiology of Depression
Inés Gallego‐Landin, Alba García-Baos, Adriana Castro‐Zavala, Olga Valverde · 2021 · Frontiers in Pharmacology
Cannabidiol-Δ 9 -tetrahydrocannabinol interactions on acute pain and locomotor activity
Stevie C. Britch, Jenny L. Wiley, Zhihao Yu, Brian H. Clowers, Rebecca M. Craft · 2017 · Drug and Alcohol Dependence
Cannabidiol as a Novel Candidate Alcohol Use Disorder Pharmacotherapy: A Systematic Review
Jasmine Turna, Sabrina K. Syan, Benicio Noronha Frey, Brian R. Rush, Mary Jean Costello, Mark Weiss, James M. MacKillop · 2019 · Alcoholism Clinical and Experimental Research
Structural Insights into CB1 Receptor Biased Signaling
Rufaida M. Al-Zoubi, Paula Morales, Patricia H. Reggio · 2019 · International Journal of Molecular Sciences
Phytocannabinoids: Useful Drugs for the Treatment of Obesity? Special Focus on Cannabidiol
Patrycja Bielawiec, Ewa Harasim‐Symbor, Adrian Chabowski · 2020 · Frontiers in Endocrinology
Δ 9 -Tetrahydrocannabinol and Cannabidiol Differentially Regulate Intraocular Pressure
Sally Miller, Laura Daily, Emma Leishman, Heather B. Bradshaw, Alex J. Straiker · 2018 · Investigative Ophthalmology & Visual Science
Modulation of CB1 cannabinoid receptor by allosteric ligands: Pharmacology and therapeutic opportunities
Leepakshi Khurana, Ken Mackie, Daniele Piomelli, Debra A. Kendall · 2017 · Neuropharmacology
A Review of Scientific Evidence for THC:CBD Oromucosal Spray (Nabiximols) in the Management of Chronic Pain
Michael A. Ueberall · 2020 · Journal of Pain Research
The phytochemical diversity of commercial Cannabis in the United States
Christiana J. Smith, Daniela Vergara, Brian Keegan, Nick Jikomes · 2022 · PLoS ONE
Role of Cannabidiol in the Therapeutic Intervention for Substance Use Disorders
Francisco Navarrete, María S. García‐Gutiérrez, Ani Gasparyan, Amaya Austrich-Olivares, Jorge Manzanares · 2021 · Frontiers in Pharmacology
Cannabidiol Treatment Might Promote Resilience to Cocaine and Methamphetamine Use Disorders: A Review of Possible Mechanisms
Claudia Calpe-López, María Pilar García-Pardo, M.A. Aguilar · 2019 · Molecules
Crosstalk between the transcriptional regulation of dopamine D2 and cannabinoid CB1 receptors in schizophrenia: Analyses in patients and in perinatal Δ9-tetrahydrocannabinol-exposed rats
Martina Di Bartolomeo, Tibor Štark, Oriana Maria Maurel, Fabio Arturo Iannotti, Martin Kuchař, Jana Kučerová, Fabiana Piscitelli, Samuele Laudani, Vladimír Pekařík, Salvatore Salomone et al. · 2020 · Pharmacological Research
Endocannabinoid System as a Promising Therapeutic Target in Inflammatory Bowel Disease – A Systematic Review
Szymon Hryhorowicz, Marta Kaczmarek-Ryś, Aleksandra Zielińska, Rodney John Scott, Ryszard Słomski, Andrzej Pławski · 2021 · Frontiers in Immunology
Oral Administration of Cannabis and Δ-9-tetrahydrocannabinol (THC) Preparations: A Systematic Review
Lourdes Poyatos, Ana Pilar Pérez-Acevedo, Esther Papaseit, Clara Pérez‐Mañá, Soraya Martín, Olga Hladun, Adrià Siles, Marta Torrens, Francesco Paolo Busardò, Magı́ Farré · 2020 · Medicina
Molecular and functional interaction between GPR18 and cannabinoid CB2 G-protein-coupled receptors. Relevance in neurodegenerative diseases
Irene Reyes‐Resina, Gemma Navarro, David Aguinaga, Enric I. Canela, Clara T. Schoeder, Michał Załuski, Katarzyna Kieć‐Kononowicz, Carlos A. Saura, Christa Elisabeth Müller, Rafael Franco · 2018 · Biochemical Pharmacology
Cannabidiol binding and negative allosteric modulation at the cannabinoid type 1 receptor in the presence of delta-9-tetrahydrocannabinol: An In Silico study
Hery Chung, Angélica Fierro, Carlos David Pessoa-Mahana · 2019 · PLoS ONE
Cannabidiol and Sports Performance: a Narrative Review of Relevant Evidence and Recommendations for Future Research
Danielle McCartney, Melissa J. Benson, Ben Desbrow, Christopher G. Irwin, Anastasia S. Suraev, Iain S. McGregor · 2020 · Sports Medicine - Open
Cannabinoid receptor type-1: breaking the dogmas
Arnau Busquets-García, Edgar Soria Gómez, Luigi Bellocchio, Giovanni Marsicano · 2016 · F1000Research
The (Poly)Pharmacology of Cannabidiol in Neurological and Neuropsychiatric Disorders: Molecular Mechanisms and Targets
Rosa Maria Vitale, Fabio Arturo Iannotti, Pietro Amodeo · 2021 · International Journal of Molecular Sciences
In Vivo Availability of Cannabinoid 1 Receptor Levels in Patients With First-Episode Psychosis
Faith Borgan, Heikki Laurikainen, Mattia Veronese, Tiago Reis Marques, Merja Haaparanta‐Solin, Olof H. Solin, Tarik Dahoun, Maria Rogdaki, Raimo K. R. Salokangas, Max Karukivi et al. · 2019 · JAMA Psychiatry
An Overview of Cannabidiol as a Multifunctional Drug: Pharmacokinetics and Cellular Effects
Nadia Martínez Naya, Jazmin Kelly, Giuliana Corna, Michele Golino, Ariel Héctor Polizio, Antonio Abbate, Stefano A Toldo, Eleonora Mezzaroma · 2024 · Molecules
Phytocannabinoid Pharmacology: Medicinal Properties of Cannabis sativa Constituents Aside from the “Big Two”
Peter B. Sampson · 2020 · Journal of Natural Products
Cannabidiol effectively reverses mechanical and thermal allodynia, hyperalgesia, and anxious behaviors in a neuropathic pain model: Possible role of CB1 and TRPV1 receptors
Gleice Kelli Silva-Cardoso, Willian Lazarini-Lopes, Jaime E. C. Hallak, José Alexandre S. Crippa, Antônio Waldo Zuardi, Norberto Garcia‐Cairasco, Christie Ramos Andrade Leite‐Panissi · 2021 · Neuropharmacology
Neural correlates of interactions between cannabidiol and Δ 9 ‐tetrahydrocannabinol in mice: implications for medical cannabis
Stephanie M. Todd, Jonathon Carl Arnold · 2015 · British Journal of Pharmacology
Cannabidiol Reverses Deficits in Hippocampal LTP in a Model of Alzheimer’s Disease
Blathnaid Hughes, Caroline E. Herron · 2018 · Neurochemical Research
5-Chlorobenzofuran-2-carboxamides: From allosteric CB1 modulators to potential apoptotic antitumor agents
Bahaa G. M. Youssif, Ashraf M. Mohamed, Essam Eldin A. Osman, Ola F. Abou‐Ghadir, Dina H. Elnaggar, Mostafa H. Abdelrahman, Laurent Treamblu, Hesham A. M. Gomaa · 2019 · European Journal of Medicinal Chemistry
Biosynthesis and synthetic biology of psychoactive natural products
Cooper Stergis Jamieson, Joshua Misa, Yi Tang, John M. Billingsley · 2021 · Chemical Society Reviews
Use of Cannabis and Cannabinoids for Treatment of Cancer
Viktoriia Cherkasova, Bo Wang, Marta Gerasymchuk, Anna Fiselier, Olga Kovalchuk, Igor Kovalchuk · 2022 · Cancers
The Impact of Cannabidiol on Human Brain Function: A Systematic Review
Albert Batalla, Julian Bos, Amber Postma, Matthijs Geert Bossong · 2021 · Frontiers in Pharmacology
Cannabinoids in Breast Cancer: Differential Susceptibility According to Subtype
Cristina Ferreira Almeida, Natércia A. A. Teixeira, Georgina Correia‐da‐Silva, Cristina Amaral · 2021 · Molecules
Cannabidiol Enhances the Passage of Lipid Nanocapsules across the Blood–Brain Barrier Both in Vitro and in Vivo
Juan Aparicio-Blanco, Ignacio Andres Romero, David Kingsley Male, Karla Slowing, Luis García‐García, Ana Isabel Torres‐Suárez · 2019 · Molecular Pharmaceutics
Antidepressant-like effects of β-caryophyllene on restraint plus stress-induced depression
Eun‐Sang Hwang, Hyun-Bum Kim, Seok Lee, Min Jeong Kim, Kwan-Joong Kim, Gaeul Han, Se-Young Han, Eun-A Lee, Jeong-Hee Yoon, Dae‐Ok Kim et al. · 2019 · Behavioural Brain Research
Cannabidiol activates neuronal Kv7 channels
Han-Xiong Bear Zhang, Laurel M. Heckman, Zachary Niday, Sooyeon Jo, Akie Fujita, Jaehoon Shim, Roshan Pandey, Hoor Al Jandal, Selwyn S. Jayakar, Lee B Barrett et al. · 2022 · eLife
The luminescent HiBiT peptide enables selective quantitation of G protein–coupled receptor ligand engagement and internalization in living cells
Michelle E. Boursier, Sergiy Levin, Kris Zimmerman, Thomas Machleidt, Robin Hurst, Braeden L. Butler, Christopher T. Eggers, Thomas A. Kirkland, Keith V. Wood, Rachel Friedman Ohana · 2020 · Journal of Biological Chemistry
Cannabidiolic acid methyl ester, a stable synthetic analogue of cannabidiolic acid, can produce 5‐HT1A receptor‐mediated suppression of nausea and anxiety in rats
Roger G. Pertwee, Erin M. Rock, Kelsey G. Guenther, Cheryl L. Limebeer, Lesley Stevenson, Christeene G. Haj, Reem Smoum, Linda A. Parker, Raphael Mechoulam · 2017 · British Journal of Pharmacology
The Entourage Effect in Cannabis Medicinal Products: A Comprehensive Review
Rebeca André, Ana Patrícia Gomes, Catarina Pereira‐Leite, António Marques da Costa, Luís Monteiro Rodrigues, Michael Sassano, Patrícia Mendonca Rijo, Maria do Céu Costa · 2024 · Pharmaceuticals
Novel Electrophilic and Photoaffinity Covalent Probes for Mapping the Cannabinoid 1 Receptor Allosteric Site(s)
Pushkar M. Kulkarni, Abhijit Kulkarni, Anisha Korde, Ritesh B. Tichkule, Robert B. Laprairie, Eileen M. Denovan‐Wright, Han Zhou, David R. Janero, Nikolai Zvonok, Alexandros Makriyannis et al. · 2015 · Journal of Medicinal Chemistry
Cannabidiol attenuates insular dysfunction during motivational salience processing in subjects at clinical high risk for psychosis
Robin Paul Wilson, Matthijs Geert Bossong, Elizabeth Appiah‐Kusi, Natalia Petros, Michael John Brammer, Jesús Pérez, Paul Allen, Philip K. McGuire, Sagnik Bhattacharyya · 2019 · Translational Psychiatry
The Effectiveness of Cannabinoids in the Treatment of Posttraumatic Stress Disorder (PTSD): A Systematic Review
Chandni Hindocha, Janna Cousijn, M. Rall, Michael Bloomfield · 2019 · Journal of Dual Diagnosis
Positron Emission Tomography Imaging of the Endocannabinoid System: Opportunities and Challenges in Radiotracer Development
Lu Hou, Jian Rong, Ahmed Haider, Daisuke Ogasawara, Cassis Varlow, Michael A. Schafroth, Linjing Mu, Jiefeng Gan, Hao Xu, Christopher John Fowler et al. · 2020 · Journal of Medicinal Chemistry
Cannabidiol Use for Fibromyalgia: Prevalence of Use and Perceptions of Effectiveness in a Large Online Survey
Kevin F. Boehnke, Joel Joseph Gagnier, Lynne Kennedy Matallana, David A. Williams · 2021 · Journal of Pain
Decoding the Postulated Entourage Effect of Medicinal Cannabis: What It Is and What It Isn’t
Catalina Christensen, Martin Rose, Claus Cornett, Morten Allesø · 2023 · Biomedicines
Quantitative Analyses of Synergistic Responses between Cannabidiol and DNA-Damaging Agents on the Proliferation and Viability of Glioblastoma and Neural Progenitor Cells in Culture
Liting Deng, Lindsay Ng, Tatsuya Ozawa, Nephi Stella · 2016 · Journal of Pharmacology and Experimental Therapeutics
Can Hemp Help? Low-THC Cannabis and Non-THC Cannabinoids for the Treatment of Cancer
Farjana Afrin, Mengna Chi, Andrew Leigh Eamens, Ryan J. Duchatel, Alicia M. Douglas, Jennifer Schneider, Craig A. Gedye, Ameha Seyoum Woldu, Matthew D. Dun · 2020 · Cancers
miRNA expression profiles and molecular networks in resting and LPS-activated BV-2 microglia—Effect of cannabinoids
Ana Juknat, Fuying Gao, Giovanni Coppola, Zvi Vogel, Ewa Kozela · 2019 · PLoS ONE
In Vitro and Clinical Evaluation of Cannabigerol (CBG) Produced via Yeast Biosynthesis: A Cannabinoid with a Broad Range of Anti-Inflammatory and Skin Health-Boosting Properties
Eduardo Pérez, José Ramón Fernández, Corey Fitzgerald, Karl Rouzard, Masanori Tamura, Christopher K. Savile · 2022 · Molecules
Δ-9-Tetrahydrocannabinol and Cannabidiol produce dissociable effects on prefrontal cortical executive function and regulation of affective behaviors
Hanna J. Szkudlarek, Sagar J. Desai, Justine Renard, Brian J.G. Pereira, Christopher Norris, Christina E. L. Jobson, Nagalingam Rajakumar, Brian Leonard Allman, Steven R. Laviolette · 2018 · Neuropsychopharmacology
A Conversion of oral cannabidiol to delta9-tetrahydrocannabinol seems not to occur in humans
Nahler, Gerhard, Grotenhermen, Franjo, Zuardi, Antonio Waldo, Crippa, José A.S. · 2017 · Cannabis & Cannabinoid Research
Cannabis and the Developing Adolescent Brain
Adina S. Fischer, Susan Frances Tapert, Dexter Louie, Alan F. Schatzberg, Manpreet Kaur Singh · 2020 · Current Treatment Options in Psychiatry
The neuropharmacology of cannabinoid receptor ligands in central signaling pathways
Tibor M. Brunt, Matthijs Geert Bossong · 2020 · European Journal of Neuroscience
Cannabis-Derived Compounds Cannabichromene and Δ9-Tetrahydrocannabinol Interact and Exhibit Cytotoxic Activity against Urothelial Cell Carcinoma Correlated with Inhibition of Cell Migration and Cytoskeleton Organization
Omer Anis, A. C. Vinayaka, Nurit Shalev, Dvora Namdar, Stalin Nadarajan, Seegehalli M. Anil, Ofer Cohen, Eduard Belausov, J. Ramon, Einav Mayzlish Gati et al. · 2021 · Molecules
Cannabidiol inhibits the skeletal muscle Nav1.4 by blocking its pore and by altering membrane elasticity
Mohammad‐Reza Ghovanloo, Koushik Choudhury, Tagore Sanketh Bandaru, Mohamed A. Fouda, Kaveh Rayani, Radda Rusinova, Tejas Phaterpekar, Karen Nelkenbrecher, Abeline R. Watkins, Damon Poburko et al. · 2021 · The Journal of General Physiology
A scoping review of the use of cannabidiol in psychiatric disorders
Anna E. Kirkland, Matthew C. Fadus, Staci A. Gruber, Kevin Michael Gray, Timothy E. Wilens, Lindsay M. Squeglia · 2021 · Psychiatry Research
Tetrahydrocannabinol and cannabidiol medicines for chronic pain and mental health conditions
Jeremy David Henson, Luis Vitetta, Sean Hall · 2022 · Inflammopharmacology
Cannabidiol and brain function: current knowledge and future perspectives
Moniek Schouten, Sebastiaan Dalle, Dante Mantini, Katrien Koppo · 2024 · Frontiers in Pharmacology
G protein-coupled receptors in acquired epilepsy: Druggability and translatability
Ying Yu, Davis T. Nguyen, Jianxiong Jiang · 2019 · Progress in Neurobiology
Prediction of the Binding Affinities and Selectivity for CB1 and CB2 Ligands Using Homology Modeling, Molecular Docking, Molecular Dynamics Simulations, and MM-PBSA Binding Free Energy Calculations
Beihong Ji, Shuhan Liu, Xibing He, Viet Hoang Man, Xiang‐Qun Xie, Junmei Wang · 2020 · ACS Chemical Neuroscience